Dec 18 2009
TSO3 Inc. ("TSO3") (TSX: TOS), an innovator of low temperature sterilization technology using ozone for medical devices in healthcare settings, today announced that Health Canada has approved the STERIZONE(R) 125L+ Sterilizer for sale in Canada.
The STERIZONE(R) 125L+ Sterilizer offers three new cycles in a single sterilizer and meets healthcare demands for speed and compatibility that previously required two or more sterilization systems. The device will be available through 3M Canada's distribution in 2010.
"This market clearance in Canada is perfectly timed with our recently announced distribution agreement with 3M, a global leader in infection prevention," stated R.M. (Ric) Rumble, CEO, TSO3. "The partnership with 3M adds credibility and channel strength, and we are working with 3M Canada to capitalize on the opportunity."
TSO3's new low temperature sterilization system offers speed, high throughput, increased instrument compatibility, and cost effective sterilization, and is engineered to be safe and eco-friendly. The new cycles accommodate general surgical instruments, and short and long, rigid or flexible endoscopes including complex multi-channel devices.
"Hospitals are actively looking for a complete low temperature solution and the STERIZONE(R) 125L+ Sterilizer meets those requirements," said Melanie Rice, Marmketing Supervisor, Infection Prevention Solutions, 3M Canada. "Based on calls received after announcing yesterday's distribution agreement, 3M Canada looks forward to expanding its product offering with TSO3's new sterilizer to better meet customer needs", concluded Ms Rice.
Source:
TSO3 INC.